Post-Assessment: Undetectable=Untransmittable: Building Hope and Ending HIV Stigma

Thank you for your participation in our second webinar in our WATCH! 2017 treatment advocacy series. The WATCH! 2017 treatment advocacy series will consist of 3-6 webinars throughout the year. In a change from prior years, The Well Project will issue certificates of completion for each 1.5 hour webinar to participants who attend the live webinar (or view the recording) and complete the pre- and post-assessment tests. The webinars will be recorded for those who are unable to participate live and will be accessible for one month after they initially take place. If you are accessing the recording of the webinar, you still need to complete the pre- and post-assessments.

Please take the post-assessment test below for the second in our WATCH! 2017 series "Undetectable=Untransmittable: Building Hope and Ending HIV Stigma" by August 19, 2017.

Question Title

* 1. Please write your first name, last name and email (required)

Question Title

* 2. Please tell us a little more about yourself (optional)

Question Title

* 3. A person with an undetectable viral load cannot transmit HIV to a partner who is HIV-negative

Question Title

* 4. Which of the following is true of Treatment as Prevention (TasP)?

Question Title

* 5. According to a recent study, most women living with HIV know about U=U

Question Title

* 6. Having an undetectable viral load means that a woman can’t transmit HIV through breastfeeding

Question Title

* 7. Because of U=U, laws criminalizing the transmission of HIV are no longer in effect

Question Title

* 8. Which of the following is true about the U=U campaign that was launched by the Prevention Access Campaign?

Question Title

* 9. On a scale of 1 (being the least effective) and 5 (being the most effective), please rate your knowledge on the topic BEFORE the webinar.

Question Title

* 10. On a scale of 1 (being the least effective) and 5 (being the most effective), please rate your knowledge on the topic AFTER the webinar.

Question Title

* 11. On a scale of 1 (being least likely) to 5 (being most likely), please indicate the likelihood you will share the information from this webinar with others.

Question Title

* 12. With whom would you share the information? (Please check all that apply)

Question Title

* 13. How did you view this webinar?

Question Title

* 14. If listen only, please provide the following:

Question Title

* 15. Please provide any additional comments/feedback about the webinar (and be sure to check out the fact sheet on this topic by clicking here!)

 
100% of survey complete.

T